vs
SUTRO BIOPHARMA, INC.（STRO）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是SWK Holdings Corp的1.3倍（$11.6M vs $8.7M），SUTRO BIOPHARMA, INC.同比增速更快（-21.4% vs -29.7%），过去两年SUTRO BIOPHARMA, INC.的营收复合增速更高（-5.4% vs -12.5%）
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
STRO vs SWKH — 直观对比
营收规模更大
STRO
是对方的1.3倍
$8.7M
营收增速更快
STRO
高出8.3%
-29.7%
两年增速更快
STRO
近两年复合增速
-12.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.6M | $8.7M |
| 净利润 | — | $-19.4M |
| 毛利率 | — | — |
| 营业利润率 | — | 9.9% |
| 净利率 | — | — |
| 营收同比 | -21.4% | -29.7% |
| 净利润同比 | 35.4% | -430.2% |
| 每股收益（稀释后） | — | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收STROSWKH
| Q4 25 | $11.6M | $8.7M | ||
| Q3 25 | $9.7M | $10.9M | ||
| Q2 25 | $63.7M | $10.1M | ||
| Q1 25 | $17.4M | $11.8M | ||
| Q4 24 | $14.8M | $12.4M | ||
| Q3 24 | $8.5M | $10.4M | ||
| Q2 24 | $25.7M | $10.8M | ||
| Q1 24 | $13.0M | $11.4M |
净利润STROSWKH
| Q4 25 | — | $-19.4M | ||
| Q3 25 | $-56.9M | $8.8M | ||
| Q2 25 | $-11.5M | $3.5M | ||
| Q1 25 | $-76.0M | $4.5M | ||
| Q4 24 | $-72.4M | $5.9M | ||
| Q3 24 | $-48.8M | $3.5M | ||
| Q2 24 | $-48.0M | $3.7M | ||
| Q1 24 | $-58.2M | $468.0K |
营业利润率STROSWKH
| Q4 25 | — | 9.9% | ||
| Q3 25 | -499.9% | 61.3% | ||
| Q2 25 | -5.2% | 46.1% | ||
| Q1 25 | -393.8% | 68.6% | ||
| Q4 24 | -440.7% | 44.7% | ||
| Q3 24 | -797.2% | 39.2% | ||
| Q2 24 | -189.4% | 8.3% | ||
| Q1 24 | -435.0% | 9.5% |
净利率STROSWKH
| Q4 25 | — | — | ||
| Q3 25 | -586.6% | 80.7% | ||
| Q2 25 | -18.0% | 35.2% | ||
| Q1 25 | -436.6% | 38.4% | ||
| Q4 24 | -489.2% | 47.5% | ||
| Q3 24 | -572.6% | 33.3% | ||
| Q2 24 | -186.8% | 33.9% | ||
| Q1 24 | -447.5% | 4.1% |
每股收益（稀释后）STROSWKH
| Q4 25 | — | $-1.59 | ||
| Q3 25 | $-0.67 | $0.72 | ||
| Q2 25 | $-0.14 | $0.29 | ||
| Q1 25 | $-0.91 | $0.37 | ||
| Q4 24 | $-27.63 | $0.47 | ||
| Q3 24 | $-0.59 | $0.28 | ||
| Q2 24 | $-0.59 | $0.30 | ||
| Q1 24 | $-0.59 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $141.4M | $42.8M |
| 总债务越低越好 | — | $33.0M |
| 股东权益账面价值 | $-132.5M | $235.1M |
| 总资产 | $173.8M | $272.4M |
| 负债/权益比越低杠杆越低 | — | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资STROSWKH
| Q4 25 | $141.4M | $42.8M | ||
| Q3 25 | $167.6M | $10.2M | ||
| Q2 25 | $205.1M | $8.0M | ||
| Q1 25 | $249.0M | $29.8M | ||
| Q4 24 | $316.9M | $5.9M | ||
| Q3 24 | $388.3M | $17.2M | ||
| Q2 24 | $375.6M | $5.5M | ||
| Q1 24 | $267.6M | $5.5M |
总债务STROSWKH
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
股东权益STROSWKH
| Q4 25 | $-132.5M | $235.1M | ||
| Q3 25 | $-87.3M | $254.2M | ||
| Q2 25 | $-32.1M | $246.5M | ||
| Q1 25 | $-25.8M | $292.7M | ||
| Q4 24 | $44.6M | $288.7M | ||
| Q3 24 | $111.2M | $283.4M | ||
| Q2 24 | $152.2M | $282.8M | ||
| Q1 24 | $98.0M | $279.9M |
总资产STROSWKH
| Q4 25 | $173.8M | $272.4M | ||
| Q3 25 | $209.7M | $289.4M | ||
| Q2 25 | $262.4M | $285.7M | ||
| Q1 25 | $321.4M | $331.3M | ||
| Q4 24 | $387.2M | $332.2M | ||
| Q3 24 | $451.8M | $321.3M | ||
| Q2 24 | $489.0M | $321.0M | ||
| Q1 24 | $403.4M | $322.0M |
负债/权益比STROSWKH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-177.2M | $27.3M |
| 自由现金流经营现金流 - 资本支出 | — | $26.8M |
| 自由现金流率自由现金流/营收 | — | 308.1% |
| 资本支出强度资本支出/营收 | — | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $43.2M |
8季度趋势，按日历期对齐
经营现金流STROSWKH
| Q4 25 | $-177.2M | $27.3M | ||
| Q3 25 | $-38.2M | $906.0K | ||
| Q2 25 | $-44.7M | $7.8M | ||
| Q1 25 | $-67.9M | $8.3M | ||
| Q4 24 | $-71.7M | $23.0M | ||
| Q3 24 | $-64.5M | $6.3M | ||
| Q2 24 | $9.5M | $5.4M | ||
| Q1 24 | $-64.7M | $4.4M |
自由现金流STROSWKH
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $8.2M | ||
| Q4 24 | — | $22.9M | ||
| Q3 24 | — | $6.3M | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | — | — |
自由现金流率STROSWKH
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 69.1% | ||
| Q4 24 | — | 185.3% | ||
| Q3 24 | — | 60.4% | ||
| Q2 24 | — | 49.7% | ||
| Q1 24 | — | — |
资本支出强度STROSWKH
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.0% |
现金转化率STROSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
STRO
暂无分部数据
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
